Author:
Mozas Pablo,Rivero Andrea,López-Guillermo Armando
Funder
Fundación Española de Hematología y Hemoterapia
Reference75 articles.
1. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France;Swerdlow,2017
2. Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study;Bachy;J Clin Oncol,2019
3. Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era;Rivas-Delgado;Br J Haematol,2019
4. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study;Casulo;J Clin Oncol,2015
5. Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group;Alonso-Álvarez;Br J Haematol,2017
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献